tiprankstipranks
Trending News
More News >
Mangalam Organics Ltd (IN:MANORG)
:MANORG
India Market
Advertisement

Mangalam Organics Ltd (MANORG) AI Stock Analysis

Compare
0 Followers

Top Page

IN:MANORG

Mangalam Organics Ltd

(MANORG)

Rating:57Neutral
Price Target:
₹530.00
▲(8.57% Upside)
Mangalam Organics' overall stock score is primarily influenced by its financial performance, which shows revenue growth and operational efficiency but is hampered by weak profitability and cash flow issues. Technical analysis indicates bearish momentum, while valuation is moderate. The absence of earnings call data and corporate events means these factors do not impact the score.

Mangalam Organics Ltd (MANORG) vs. iShares MSCI India ETF (INDA)

Mangalam Organics Ltd Business Overview & Revenue Model

Company DescriptionMangalam Organics Ltd (MANORG) is a leading manufacturer in the chemical industry, primarily engaged in the production and distribution of terpene and resin-based products. The company operates in sectors including industrial chemicals, essential oils, and specialty chemicals, catering to a variety of industries such as paints, adhesives, rubber, and pharmaceuticals. With a focus on sustainability and innovation, Mangalam Organics Ltd has established itself as a key player in the organic chemicals market.
How the Company Makes MoneyMangalam Organics Ltd generates revenue through the manufacturing and sale of its core product lines, which include terpene and resin-based chemicals. These products are essential raw materials for various industrial applications, including the production of adhesives, coatings, and fragrances. The company earns money by supplying these chemicals to a diverse customer base across multiple industries. Additionally, Mangalam Organics may engage in strategic partnerships and contracts with other industrial players to enhance its market reach and distribution capabilities, further contributing to its revenue streams.

Mangalam Organics Ltd Financial Statement Overview

Summary
Mangalam Organics demonstrated strong revenue growth and improved gross profit margins. However, the low net profit margin, negative free cash flow, and low return on equity indicate profitability and liquidity challenges.
Income Statement
65
Positive
Mangalam Organics exhibited a strong revenue growth of 7.39% from 2024 to 2025, with an improved gross profit margin of 48.40% in 2025, up from 22.89% in 2024. However, the net profit margin remains low at 2.38% due to increased expenses, limiting profitability. The EBIT and EBITDA margins also show improvement, indicating efficient operations despite the low net income.
Balance Sheet
58
Neutral
The company has a moderate debt-to-equity ratio of 0.93 in 2025, indicating a balanced use of debt and equity. The return on equity (ROE) is low at 4.29%, reflecting limited profitability relative to shareholder investment. The equity ratio is satisfactory at 47.02%, suggesting a stable financial structure but highlighting potential risks if profits do not improve.
Cash Flow
52
Neutral
Cash flow performance is concerning, with negative free cash flow growth of -329.40% from 2024 to 2025. Operating cash flow turned negative, indicating cash generation issues. The operating cash flow to net income ratio is negative, suggesting operational inefficiencies. These factors pose a risk to liquidity and future investment capability.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue5.30B4.94B4.93B4.91B3.38B
Gross Profit2.57B1.13B701.20M1.47B1.72B
EBITDA589.13M390.38M-24.27M924.25M1.28B
Net Income125.97M42.86M-272.25M537.43M847.79M
Balance Sheet
Total Assets6.24B4.85B5.06B5.60B3.11B
Cash, Cash Equivalents and Short-Term Investments189.27M20.19M12.79M12.78M343.55M
Total Debt2.72B1.73B1.90B2.12B243.11M
Total Liabilities3.30B2.05B2.30B2.56B596.26M
Stockholders Equity2.93B2.81B2.76B3.04B2.52B
Cash Flow
Free Cash Flow-751.15M327.48M361.57M-1.84B-27.60M
Operating Cash Flow-78.44M727.23M769.23M-841.04M262.79M
Investing Cash Flow-670.47M-395.09M-407.80M-995.25M-281.47M
Financing Cash Flow736.26M-325.52M-355.77M1.83B22.66M

Mangalam Organics Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price488.15
Price Trends
50DMA
545.56
Negative
100DMA
494.21
Negative
200DMA
469.16
Positive
Market Momentum
MACD
-21.41
Negative
RSI
34.72
Neutral
STOCH
43.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MANORG, the sentiment is Negative. The current price of 488.15 is below the 20-day moving average (MA) of 495.04, below the 50-day MA of 545.56, and above the 200-day MA of 469.16, indicating a neutral trend. The MACD of -21.41 indicates Negative momentum. The RSI at 34.72 is Neutral, neither overbought nor oversold. The STOCH value of 43.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MANORG.

Mangalam Organics Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (44)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
₹5.50B67.18
2.99%45.21%
67
Neutral
₹5.37B5.86
1.30%13.38%47.27%
63
Neutral
₹3.95B25.86
25.15%-16.39%
58
Neutral
₹1.16B19.78
-16.39%-409.96%
57
Neutral
₹4.39B19.01
11.14%308.52%
44
Neutral
C$923.76M-8.68-0.23%2.69%24.53%-41.45%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:MANORG
Mangalam Organics Ltd
538.15
85.50
18.89%
IN:AARTISURF
Aarti Surfactants Ltd.
466.75
-159.60
-25.48%
IN:INTLCONV
International Conveyors Ltd.
84.94
7.44
9.60%
IN:MAHASTEEL
Mahamaya Steel Industries Ltd.
345.95
227.65
192.43%
IN:MANGALAM
Mangalam Drugs & Organics Ltd.
74.54
-37.86
-33.68%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 13, 2025